FDA Adverse Event Death Summary report: N

PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 2957046 · Received February 12, 2013

Report

Report Number
2024168-2013-00809
Event Type
Death
Date Received
February 12, 2013
Date of Event
May 19, 2012
Report Date
January 18, 2013
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THERE WERE NO REPORTED PRODUCT DEFICIENCIES. THE REPORTED PATIENT EFFECT OF DEATH IS LISTED IN THE PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEM INSTRUCTIONS FOR USE AS A KNOWN ADVERSE EVENT. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT AND THE RELATIONSHIP TO THE DEVICE IF ANY CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING.

Additional Manufacturer Narrative · 1

(B)(4). YOU ARE RECEIVING THIS MDR REPORT FROM ABBOTT VASCULAR BECAUSE BOSTON SCIENTIFIC CORPORATION DISTRIBUTES PROMUS AS ITS OWN BRAND LABELING OF ABBOTT VASCULARS DRUG ELUTING STENT IN THE U.S. THE STENT REMAINS IN THE PATIENT. A FOLLOW-UP WILL BE SUBMITTED WITH ALL RELEVANT INFORMATION.

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

NEW INFORMATION REPORTED THAT THE PATIENT HAD MESOTHELIOMA AND DIED AFTER LUNG BIOPSY.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON (B)(6) 2010, THE PATIENT PRESENTED WITH DYSPNEA ON EXERTION. THE PROMUS STENT WAS IMPLANTED IN THE FIRST OBTUSE MARGINAL VESSEL. POST-PROCEDURAL STENOSIS WAS 0% WITH TIMI III FLOW. THE PATIENT WAS DISCHARGED THE NEXT DAY. ON (B)(6) 2012, THE PATIENT DIED AT HOME. NO OTHER INFORMATION IS AVAILABLE ABOUT THE CAUSE OF DEATH. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
61439 PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT

Patients

Seq Age Sex Outcome Treatment
1 73 YR Death